How Do We Define Cure of Diabetes?
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The mission of the American Diabetes Association is “to prevent and cure diabetes and to improve the lives of all people affected by diabetes.” Increasingly, scientific and medical articles ( 1) and commentaries ( 2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes. Several approved or experimental treatments for type 1 and type 2 diabetes (e.g., pancreas or islet transplants, immunomodulation, bariatric/metabolic surgery) are of curative intent or have been portrayed in the media as a possible cure. However, defining remission or cure of diabetes is not as straightforward as it may seem. Unlike “dichotomous” diseases such as many malignancies, diabetes is defined by hyperglycemia, which exists on a continuum and may be impacted over a short time frame by everyday treatment or events (medications, diet, activity, intercurrent illness). The distinction between successful treatment and cure is blurred in the case of diabetes. Presumably improved or normalized glycemia must be part of the definition of remission or cure. Glycemic measures below diagnostic cut points for diabetes can occur with ongoing medications (e.g., antihyperglycemic drugs, immunosuppressive medications after a transplant), major efforts at lifestyle change, a history of bariatric/metabolic surgery, or ongoing procedures (such as repeated replacements of endoluminal devices). Do we use the terms remission or cure for all patients with normal glycemic measures, regardless of how this is achieved?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some studies [54–57] subdivided results as previously proposed by Buse et al. [58].”
The cited source says what the claim attributes to it.
In the citing paper
“Sustained improvements over two years were observed with high (74 %) retention, of whom 19 % achieved remission by the definition of Buse et al. [1] and 25 % according to the Riddle et al. 2021 international consensus definition [2].”
The cited source says what the claim attributes to it.
In the citing paper
“Firstly, the definition of remission of diabetes is the subject of considerable debate, specifically with regards to threshold levels of HbA1c/fasting glucose, use of diabetes medication, and the length of follow-up time meeting these criteria.60”
In the citing paper
“The Look AHEAD Trial, the Diabetes Remission Clinical Trial (DiRECT) and the Diabetes Intervention Accentuating Diet and Enhancing Metabolism (DIADEM-I) highlighted the potential for T2DM remission, defined as the maintenance of euglycemia (complete remission) or prediabetes level of glycemia (partial remission) with no diabetes medication for at least 1 year, with a weight loss of 15 kg or more”
From Effects of diet, lifestyle, Chrononutrition and alternative dietary interventions on postprandial Glycemia and insulin resistance (2022) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dixon, J. B., O’Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S., Proietto, J., Bailey, M., & Anderson, M. (2008) · JAMA · doi:10.1001/jama.299.3.316 · Cited by 1,434 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundCan Diabetes Be Cured? Potential Biological and Mechanical Approaches
Saudek, C. D. (2009) · JAMA · doi:10.1001/jama.2009.508 · Cited by 26 · cited 1×
“” Increasingly, scientific and medical articles (1) and commentaries (2) about diabetes interventions use the terms “remission” and “cure” as possible outcomes.”
BackgroundBarnes, E. (2007) · Chronic Illness · doi:10.1177/1742395307085333 · Cited by 17
Cited by
Items 401–500 of 1,000
Pathophysiology, Diagnostic Criteria, and Approaches to Type 2 Diabetes Remission
Khamis, A. M. (2023) · Cureus · doi:10.7759/cureus.33908 · Cited by 23
“Similar outcomes are frequently observed following bariatric surgery, with weight loss reaching 40 kg in 1-2 years following surgery and a remission rate of 70%-80% [22].”
BackgroundResultRamos-Levi, A. M., & Rubio, M. Á. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.04.006 · Cited by 22
“Cure is defined as restoration to good health, while remission is defined as reduction or disappearance of signs and symptoms of a disease.(19) Due to the chronicity of T2D, it seems reasonable and more accurate to use the term remission, which will be the one used throughout this review.”
BackgroundMethodInfluentialBiochemical consequences of bariatric surgery for extreme clinical obesity
Sarker, A., Meek, C. L., & Park, A. J. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215588116 · Cited by 20
“The American Diabetes Association now has criteria for assessment of the effects of bariatric surgery on optimization of metabolic status.(33) For type 2 diabetes, complete remission is defined as plasma glucose concentrations in the normoglycaemic range for at least one year, with no active pharmacological therapy or…”
BackgroundChanges in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status
Carlsson, E. R., Grundtvig, J. L. G., Madsbad, S., & Fenger, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00172 · Cited by 20
Faucher, P., Aron‐Wisnewsky, J., Ciangura, C., Genser, L., Torcivia, A., Bouillot, J., Poitou, C., & Oppert, J. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04037-6 · Cited by 22
Bariatric surgery outcomes: a single-center study in the United Arab Emirates
Abdi, S., Abusnana, S., Tagure, B., Elbagir, M. N., & Maleckas, A. (2015) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s87861 · Cited by 23
C-peptide levels predict type 2 diabetes remission after bariatric surgery.
Ramos-Levi, A. M., Matía, P., Cabrerizo, L., Barabash, A., Torrejón, M. J., Sánchez-Pernaute, A., Torres, A. J., & Rubio, M. Á. (2013) · PubMed · doi:10.3305/nh.2013.28.5.6554 · Cited by 20
Manning, S., Carter, N. C., Pucci, A. B. F., Jones, A., Elkalaawy, M., Cheung, W.-H., Mohammadi, B., Finer, N., Fiennes, A., Hashemi, M., et al. (2014) · BMC Obesity · doi:10.1186/2052-9538-1-12 · Cited by 22
“5%/48 mmol/mol beyond one year and no active pharmacologic therapy) [32].”
BackgroundPredictors of Short-Term Diabetes Remission After Laparoscopic Roux-en-Y Gastric Bypass
Iacobellis, G., Xu, C., Campo, R. E., & Cruz-Munoz, N. F. D. L. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1477-6 · Cited by 23
“Definition for Diabetes Remission Diabetes remission was defined HbA1c ≤6 % and FBG 100 mg/dl in absence of all diabetic medications, as per ADA [25].”
BackgroundInfluentialZhang, H., Di, J., Yu, H., Han, X., Li, K., & Zhang, P. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1666-y · Cited by 19
“0 mmol/L for 1 year or more without active pharmacologic intervention [17].”
BackgroundClinical considerations for the management of residual diabetes following bariatric surgery
Kashyap, S. R., & Schauer, P. R. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01577.x · Cited by 20
“Although many observational studies document the effectiveness of bariatric surgery to treat diabetes in the setting of morbid obesity, recent studies document that a growing number of patients (25–40%) with type 2 diabetes do not achieve ‘biochemical remission’ of hyperglycaemia defined as normal glycaemic control (H…”
BackgroundGoh, Y. M., Toumi, Z., & Date, R. S. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-4952-4 · Cited by 19
Ciudin, A., Fidilio, E., Ortiz-Zúñiga, Á., Pich, S., Salas, E., Mesa, J., Hernández, C., Simó‐Servat, O., Lecube, A., & Simó, R. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8070964 · Cited by 21
“In T2D patients, the multivariate logistic regression equation for the prediction of weight loss response (%EWL > 75%) after BS (NiC-Bariatric-D) included SNPs associated with weight loss in response to hypocaloric diet, SNPs associated to response to BS [9], and SNPs associated to response to lifestyle interventions…”
BackgroundMetabolic Changes and Diabetes Microvascular Complications 5 Years After Obesity Surgery
Miras, A. D., Ravindra, S., Humphreys, A., Lascaratos, G., Quartey, K. N. K., Ahmed, A., Cousins, J., Moorthy, K., Purkayastha, S., Hakky, S., et al. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04095-w · Cited by 20
Karaca, F. C. (2020) · Obesity Surgery · doi:10.1007/s11695-019-04326-0 · Cited by 20
Guerron, A. D., Pérez, J. E., Risoli, T. J., Lee, H., Portenier, D. D., & Corsino, L. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.05.010 · Cited by 19
Soong, T., Lee, M.-H., Lee, W., Chen, J., Wu, C., & Chun, S.-C. (2020) · Obesity Surgery · doi:10.1007/s11695-020-05093-z · Cited by 20
“The ABCD Diabetes Surgery Score system consists of four variables: age, BMI, C-peptide level, and duration of diabetes [21, 22].”
BackgroundRangel-Zúñiga, O. A., Vals‐Delgado, C., Alcala-Diaz, J. F., Quintana‐Navarro, G. M., Krylova, Y., Leon‐Acuña, A., Luque, R. M., Gómez-Delgado, F., Delgado‐Lista, J., Ordovás, J. M., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.11.001 · Cited by 20
“5%, fasting plasma glucose <126 mg/ dL, and 2-h plasma glucose after an oral glucose tolerance test (OGTT) <200 mg/dL, for at least 2 consecutive years and without the use of diabetes medication to lower blood glucose levels.(34)”
BackgroundPlaeke, P., Beunis, A., Ruppert, M., Man, J. G. D., Winter, B. Y. D., & Hubens, G. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05157-0 · Cited by 23
“Partial and complete T2DM remissions were defined in accordance with the criteria of the ADA and summarized in Table 2 of Supplementary File 1 [11].”
MethodFernández–Ananín, S., Ballester, E., Gonzalo, B., Codina, C., Miñambres, I., Pérez, A., Gich, I. J., González, S., Serrano, C., & Balagué, C. (2022) · Obesity Surgery · doi:10.1007/s11695-022-05940-1 · Cited by 22
Våge, V., Nilsen, R. M., Berstad, A., Behme, J., Sletteskog, N., Gåsdal, R., Laukeland, C., & Mellgren, G. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0775-0 · Cited by 19
“5 % without medication [16].”
InfluentialZaman, J. A., Shah, N. V., LEVERSON, G. E., Greenberg, J. A., & Funk, L. M. (2016) · Surgical Endoscopy · doi:10.1007/s00464-016-5129-x · Cited by 22
“0 mg/dL and fasting glucose\ 100 mg/ dL in the absence of pharmacologic therapy for one year [26].”
BackgroundWhat’s in a Name? Redefining Type 2 Diabetes Remission
Kalra, S., Singal, A. K., & Lathia, T. B. (2021) · Diabetes Therapy · doi:10.1007/s13300-020-00990-z · Cited by 19
Wei, J.-H., Chou, R., Huang, P., Lee, W., Chen, S.-C., & Lin, S. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.08.026 · Cited by 19
Luca, M. D., Zese, M., Bandini, G., Zappa, M. A., Bardi, U., Carbonelli, M. G., Carrano, F. M., Casella, G., Chianelli, M., Chiappetta, S., et al. (2024) · Updates in Surgery · doi:10.1007/s13304-024-01996-z · Cited by 23
“In the Italian national legal environment [12], the main requirement to include a guideline in the National Guideline System is the adoption of rigorous methodological approaches and formal revisions by the National Center for Clinical Excellence of the Ministry of Health.”
Busetto, L., Sbraccia, P., Frittitta, L., & Pontiroli, A. E. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0471-5 · Cited by 20
“Since the definition of complete diabetes remission required the absence of active pharmacologic therapy, prolonged remission may not be achieved by pharmacology therapy itself [25].”
BackgroundŞen, O., Çalıkoğlu, İ., Özgen, G., Toydemir, T., Türkçapar, A. G., & Yerdel, M. A. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.07.021 · Cited by 18
Pujianto, U., Setiawan, L. A., Rosyid, H. A., & Salah, A. M. M. (2019) · Knowledge Engineering and Data Science · doi:10.17977/um018v2i22019p58-71 · Cited by 18
“The elimination of the class label "No" is also based on that diabetes cannot be cured [25], with this statement the class value label "No" becomes irrelevant, because basically when a person has diabetes, they have readmission to the hospital with a certain period of time to control the patient's blood sugar level.”
BackgroundRemission of Type 2 Diabetes Mellitus Should Not Be the Foremost Goal after Bariatric Surgery
Ramos-Levi, A. M., Sánchez-Pernaute, A., Cabrerizo, L., Matía‐Martín, P., Barabash, A., Hernandez, C., Calle‐Pascual, A. L., Torres, A. J., & Rubio, M. Á. (2013) · Obesity Surgery · doi:10.1007/s11695-013-1032-x · Cited by 21
Type 2 Diabetes Mellitus in Patients with Mild Obesity: Preliminary Results of Surgical Treatment
Enrique Lanzarini, S., Csendes, A., Gutiérrez, L., Cuevas, P., Lembach, H., Molina, J. C., Musleh, M., Braghetto, I., Papapietro, K., Araya, V., et al. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0780-3 · Cited by 20
“0 % without using any drugs or insulin to control diabetes [19].”
BackgroundReversibility of diabetes mellitus: Narrative review of the evidence
Ang, G. Y. (2018) · World Journal of Diabetes · doi:10.4239/wjd.v9.i7.127 · Cited by 19
Borgeraas, H., Hjelmesaeth, J. S., Birkeland, K. I., Fatima, F., Grimnes, J. O., Gulseth, H. L., Halvorsen, E., Hertel, J. K., Hillestad, T. O. W., Johnson, L. K., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024573 · Cited by 18
Shen, S., Lee, W., Kasama, K., Seki, Y., Su, Y., Wong, S. K., Huang, Y. M., & Wang, W. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05239-7 · Cited by 19
Influence of diabetes surgery on gut hormones and incretins.
Papamargaritis, D., Miras, A. D., & le Roux, C. W. (2013) · PubMed · doi:10.3305/nh.2013.28.sup2.6719 · Cited by 24
Guerrero‐Pérez, F., Casajoana, A., Gómez‐Vaquero, C., Virgili, N. M., López‐Urdiales, R., Hernández-Montoliu, L., Pujol-Gebellí, J., Osorio, J., Prats, A. R., Vidal‐Alabró, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061830 · Cited by 19
Gohier, H., Guyard-Boileau, B., Tuyeras, G., Bertrand, M., Coustols-Valat, M., Guerby, P., Parant, O., Ritz, P., & Hanaire, H. P. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05373-2 · Cited by 18
“Patients with type 2 diabetes before BS but who were considered to be in remission following BS [18] were not excluded.”
BackgroundGutierrez-Mariscal, F. M., Alcala-Diaz, J. F., Quintana‐Navarro, G. M., de la Cruz, S., Torres-Peña, J. D., Cardelo, M. P., Larriva, A. P. A.-D., Malagón, M. M., Romero‐Cabrera, J. L., Ordovás, J. M., et al. (2023) · European Journal of Nutrition · doi:10.1007/s00394-022-03080-x · Cited by 17
Kim, M. K., Lee, H. H., Lee, S., Kwon, H., Baek, K., Kim, E. K., Lee, K. W., & Song, K. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2297 · Cited by 17
“5% and a fasting glucose concentration of <126 mg/dL for 1 year or more without active pharmacological therapy [12].”
BackgroundDiabetes remission and glycemic response to pre-bariatric surgery diet
Biro, S. M., Olson, D. L., Garren, M. J., & Gould, J. C. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.06.014 · Cited by 17
“Diabetes remission was defined based on a 2009 consensus definition as complete cessation of all antidiabetic medication including oral hypoglycemics, HbA1c < 6, and normal blood glucose levels [10].”
Remission of type 2 diabetes: is bariatric surgery ready for prime time?
Esposito, K., Maiorino, M. I., Petrizzo, M., Bellastella, G., & Giugliano, D. (2014) · Endocrine · doi:10.1007/s12020-014-0463-z · Cited by 18
“below the diabetic range, of at least 1 year’s duration and in the absence of active pharmacologic or surgical therapy [1].”
BackgroundRemisja cukrzycy typu 2 po leczeniu bariatrycznym — porównanie różnych procedur
Fernández‐Soto, M. L., Martín-Leyva, A., González-Jiménez, A., García-Rubio, J., Ibáñez, A. C., Zamora‐Camacho, F. J., Leyva-Martínez, M. S., Jiménez-Ríos, J. A., & Escobar‐Jiménez, F. (2017) · Endokrynologia Polska · doi:10.5603/ep.2017.0004 · Cited by 19
“Type 2 diabetes mellitus remission criteria Following ADA recommendations [15], we assumed partial type 2 diabetes mellitus remission when fasting glucose levels in plasma were 100–125 mg/dL (5.”
BackgroundDiabetes resolution after one anastomosis gastric bypass
Abu-Abeid, A., Lessing, Y., Pencovich, N., Dayan, D., Klausner, J. M., & Abu‐Abeid, S. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.10.023 · Cited by 19
Lee, P. C., Tham, K. W., Ganguly, S., Tan, H. C., Eng, A. K. H., & Dixon, J. B. (2017) · Obesity Surgery · doi:10.1007/s11695-017-3050-6 · Cited by 18
“Diabetes remission was defined as A1c ≤ 6% without the use of any concomitant diabetes medications [10].”
MethodAdami, G. F., Camerini, G. B., Papadia, F. S., Catalano, M., Carlini, F., Cordera, R., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3511-6 · Cited by 19
Dutta, D., Jaisani, R., Khandelwal, D., Ghosh, S., Malhotra, R. K., & Kalra, S. (2019) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_185_19 · Cited by 19
Ji, G., Li, W., Li, P., Tang, H., Yu, Z., Sun, X., Li, R., Zhu, L., & Zhu, S. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04534-z · Cited by 17
Jacob, E., & Avery, A. (2021) · Obesity Science & Practice · doi:10.1002/osp4.504 · Cited by 20
Diabetes remission and relapse after metabolic surgery
Chen, X., & Kong, X. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12871 · Cited by 18
(2020) · doi:10.1136/bmj.n262 · Cited by 16
Arias-Marroquín, A. T., Razo-Olvera, F. M. D., Castañeda-Bernal, Z. M., Cruz-Juárez, E., Camacho-Ramírez, M. F., Elías-López, D., de Lara-Sánchez, M. A. Á., Chalita-Ramos, L., Rebollar-Fernández, V., & Aguilar-Salinas, C. A. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01545-2 · Cited by 18
“The concept of “diabetes remission” has evolved since its initial introduction by the American Diabetes Association (ADA) in 2009 [4].”
Benaiges, D., Goday, A., Casajoana, A., Roux, J. A. F., Fitó, M., Pozo, Ó. J., Serra, C., Pera, M., Llauradó, G., Climent, E., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02296-x · Cited by 16
“Diabetes remission was defined according to American Diabetes Association criteria for complete remission: glycated hemoglobin [HbA1c] value 6.0% (42 mmol/mol) and fasting glucose level 5.6 mmol/l without diabetes medication [21].”
MethodInfluentialAdams, S., Salhab, M., Hussain, Z., Miller, G., & Leveson, S. H. (2013) · Acta Diabetologica · doi:10.1007/s00592-013-0453-2 · Cited by 16
Rubio, M. Á., Monereo, S., Lecube, A., Resa, J., Masdevall, C., Vigó, F. D. L. C., Garrido, M., Goday, A., Llorente, I., & Pesquera, C. (2013) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2013.12.001 · Cited by 16
Montastier, É., Bécouarn, G., Bérard, E., Guyonnet, S., Topart, P. A., & Ritz, P. (2016) · Obesity Surgery · doi:10.1007/s11695-015-2024-9 · Cited by 16
“The remission of the comorbidities at 2 years were defined as follows: for diabetes, glycosylated hemoglobin (HbA1c) lower than 6 %, and plasma glucose lower than 100 mg/dL, without any medication [21]; for hypertension, blood pressure lower than 140/ OBES SURG (2016) 26:1806–1813 1807”
BackgroundResultLin, S., Yang, N., Guan, W., & Liang, H. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.03.027 · Cited by 16
Holst, J. J., & Madsbad, S. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01032-y · Cited by 17
Lin, S., Li, C., Guan, W., & Liang, H. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05411-z · Cited by 17
Li, Y., Gu, Y., Jin, Y., & Mao, Z. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05520-9 · Cited by 16
Sanchís, P., Frances, C., Nicolau, J., Rivera, R., Fortuny, R., Julian, X., Pascual, S., Gómez, L. A., Rodríguez, I., Olivares, J., et al. (2014) · Obesity Surgery · doi:10.1007/s11695-014-1321-z · Cited by 19
Antidiabetic efficacy of obesity surgery in Germany: A quality assurance nationwide survey
Weiner, R. A., El-Sayes, I., Manger, T., Weiner, S. R., Lippert, H., & Stroh, C. (2013) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.07.007 · Cited by 16
Laparoscopic loop duodenaljejunal bypass with sleeve gastrectomy in type 2 diabetic patients
Hanipah, Z. N., Hsin, M.-C., Liu, C.-C., & Huang, C. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.01.016 · Cited by 16
Type 2 Diabetes Mellitus (T2DM) “Remission” in Non-bariatric Patients 65 Years and Older
Tangelloju, S., Little, B. B., Esterhay, R. J., Brock, G. N., & LaJoie, A. S. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00082 · Cited by 16
“6 mmol/l]); and c) prolonged remission, defined as complete remission for at least 5 years (4).”
BackgroundAmouyal, C., Castel, J., Guay, C., Lacombe, A., Denom, J., Migrenne, S., Rouault, C., Marquet, F., Georgiadou, E., Stylianides, T., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102895 · Cited by 19
“To avoid a potential effect of weight loss on circulating miRNA levels, we choose 20 patients from the French BARICAN cohort [65] who underwent gastric bypass and separated them into two groups depending on whether, one year after surgery, they showed T2D remission (DR) or not (NDR) as defined by the American Diabetes…”
MethodInfluentialPopulation models of diabetes mellitus by ordinary differential equations: a review
Nasir, H., & Daud, A. A. M. (2021) · Mathematical Population Studies · doi:10.1080/08898480.2021.1959817 · Cited by 16
Disease Severity and Staging of Obesity: a Rational Approach to Patient Selection
Whyte, M., Velusamy, S., & Aylwin, S. J. B. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0456-7 · Cited by 18
Heart rate variability after bariatric surgery: The add‐on value of exercise
Belzile, D., Auclair, A., Roberge, J., Piché, M., Lebel, A., Pettigrew, M., Marceau, S., Biertho, L. D., & Poirier, P. (2021) · European Journal of Sport Science · doi:10.1080/17461391.2021.2017488 · Cited by 15
“Diabetes remission was defined as fasting blood glucose 5.6 mmol/L and a HbA1c 6.0% in the absence of pharmacological treatment (Buse et al., 2009).”
BackgroundInfluentialGlycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas
Castro, M. A., Ojeda, C. M., García-Centeno, R., López-García, M.-C., Lamas, C., Hanzu, F. A., Mora, M., Tous, M. D. C., Gómez, P. R. D. V., Ramírez, P. A. P., et al. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0218 · Cited by 16
Dumping Syndrome after Bariatric Surgery
Nofal, M. N., Yousef, A. J., Alkhawaldeh, I. M., Al-Jafari, M., Zuaiter, S., & Eddin, S. Z. (2024) · Annali Italiani di Chirurgia · doi:10.62713/aic.3422 · Cited by 17
“This is accomplished through better data gathering and analysis from multiple sources [46].”
BackgroundMethodInfluentialMallipedhi, A., Min, T., Prior, S. L., MacIver, C., Luzio, S. D., Dunseath, G. J., Bracken, R. M., Islam, S., Barry, J. D., Caplin, S., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.08.009 · Cited by 15
Nedelcu, M., Loureiro, M. D. P., Skalli, M., Galtier, F., Jaussent, A., Deloze, M., Gagner, M., Fabre, J. M., & Nocca, D. (2017) · Surgery · doi:10.1016/j.surg.2017.02.018 · Cited by 17
Elshaer, A. M., Almerie, M. Q., Pellen, M., & Jain, P. K. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04782-z · Cited by 15
de Hoogh, I. M., Pasman, W. J., Boorsma, A., van Ommen, B., & Wopereis, S. (2022) · Biomedicines · doi:10.3390/biomedicines10030643 · Cited by 17
Faucher, P., Carette, C., Jannot, A., Gatta‐Cherifi, B., Straaten, A. V., Piquet, M., Raverot, G., Alligier, M., Batisse, T., Ziegler, O., et al. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06079-9 · Cited by 19
Lin, S., Li, C., Shen, J., Guan, W., & Liang, H. (2022) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2022.07.003 · Cited by 15
Ritter, S., Vetter, M. L., & Sarwer, D. B. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.07.2578 · Cited by 16
“To address these concerns, the ADA convened an expert panel to develop a consensus statement on the definition of remission.(137) “Partial remission” was defined as mild hyperglycemia (FPG level, 100–125 mg/dL [5.”
MethodIs regression to normoglycaemia clinically important?
Yakubovich, N., & Gerstein, H. C. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60828-9 · Cited by 15
Urbanavičius, V., Abalikšta, T., Brimas, G., Abraitienė, A., Gogelienė, L., & Strupas, K. (2013) · Medicina · doi:10.3390/medicina49010002 · Cited by 15
Sleeve Gastrectomy and Diabetes
Andalib, A., & Aminian, A. (2017) · Advances in Surgery · doi:10.1016/j.yasu.2017.03.003 · Cited by 18
Ricci, M. A., Ministrini, S., VUONO, S. D., Camilli, M., Gentili, A., Daviddi, G., Boni, M., & Lupattelli, G. (2017) · Angiology · doi:10.1177/0003319717718707 · Cited by 16
Jirapinyo, P., Thompson, A. C., Kröner, P. T., Chan, W. W., & Thompson, C. C. (2017) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.12.015 · Cited by 15
Petrick, A. T., Kuhn, J. E., Parker, D. M., Prasad, J., Still, C. D., & Wood, G. C. (2019) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.07.010 · Cited by 16
Madsen, L. R., Espersen, R., Ørnstrup, M. J., Jørgensen, N. R., Langdahl, B. L., & Richelsen, B. (2019) · Obesity Surgery · doi:10.1007/s11695-019-03753-3 · Cited by 17
Wang, J., Chen, P., Huang, H., Yeh, C., Chen, S., Lee, W., & Chen, C.-Y. (2021) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000602 · Cited by 14
Midterm effects of bariatric surgery in patients with insulin-treated type 2 diabetes
Ghio, B., Jiménez, A., Corcelles, R., Flores, L., Lacy, A. M., & Vidal, J. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.12.030 · Cited by 15
DIABETES REMISSION RATE IN DIFFERENT BMI GRADES FOLLOWING ROUX-EN-Y GASTRIC BYPASS
Coelho, D., de Godoy, E. P., MARREIROS, I., da Luz, V. F., Oliveira, A. G., Campos, J. M., Neto, S. D. S. C., & de Freitas, M. P. C. (2018) · ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) · doi:10.1590/0102-672020180001e1343 · Cited by 14
Experiencia en la derivación biliopancreática tipo cruce duodenal: resultados a 2, 5 y 10 años
Sorribas, M., Casajoana, A., Sobrino, L., Admella, V., Osorio, J., & Pujol-Gebellí, J. (2021) · Cirugía Española · doi:10.1016/j.ciresp.2021.01.008 · Cited by 14
Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score
Kwon, Y., Kwon, J., Ha, J., Kim, D., Cho, J., Jeon, S. M., Park, S., Hwang, J., Kim, N. H., & Park, S. S. (2021) · Gastric Cancer · doi:10.1007/s10120-021-01216-2 · Cited by 17
Ortiz-Zúñiga, Á., Forner, P. C., de Tudela, A. C., de Gordejuela, A. G. R., Comas, M., Palmas-Candia, F. X., Morer, C., Vilallonga, R., & Ciudin, A. (2022) · Journal of Laparoendoscopic & Advanced Surgical Techniques · doi:10.1089/lap.2021.0863 · Cited by 14
Hyperglycemia and Hyperlipidemia with Kidney or Liver Transplantation: A Review
D’Elia, J. A., & Weinrauch, L. A. (2023) · Biology · doi:10.3390/biology12091185 · Cited by 15
“Also, beyond the scope of this review is consensus on the definition of remission of type 2 diabetes mellitus [93,94], which may be useful as transplant recipients are treated with a variety of immunosuppressive agents.”
BackgroundChhabra, L., Liti, B., Kuraganti, G., Kaul, S., & Trivedi, N. (2013) · International Journal of Endocrinology · doi:10.1155/2013/856793 · Cited by 16
Bonaventura, A., Liberale, L., Carbone, F., Scopinaro, N., Camerini, G. B., Papadia, F. S., Cordera, R., Dallegri, F., Adami, G., & Montecucco, F. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.01.007 · Cited by 15
Huang, Z., Guo, Y. H., Liu, C., Qi, L., Zou, D., & Zhou, W. (2018) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2018.02.013 · Cited by 14
Halpern, B., & Mancini, M. C. (2019) · Obesity Reviews · doi:10.1111/obr.12837 · Cited by 14
Yamazaki, H., Wang, J., Tauchi, S., Dohke, M., Hanawa, N., Katanuma, A., Saisho, Y., Kamitani, T., Fukuhara, S., & Yamamoto, Y. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.032 · Cited by 14
Surgical Treatment of Metabolic Syndrome
Runkel, N. S. F., & Brydniak, R. (2016) · Visceral Medicine · doi:10.1159/000449110 · Cited by 14
Shokri, G., Fathi, H., Jafari‐Sabet, M., Nasrabadi, N. N., & Ataee, R. (2015) · Pharmaceutical and Biomedical Research · doi:10.18869/acadpub.pbr.1.2.20 · Cited by 15
“Untreated, diabetes can cause many complications as diabetic Ketoacidosis and nonketotic hyperosmolar coma (1).”
BackgroundThe role of bariatric surgery in the treatment of type 2 diabetes mellitus
Leong, W. B., & Taheri, S. (2012) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2012.301 · Cited by 17
Zang, X., Tong, L. X., Ma, J., Zhang, Y., Zhang, B., Huang, Y., Zhou, D., Ding, L., Zhang, L., & Zhao, L. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70033 · Cited by 14
Impact of Laparoscopic Banded Gastric Bypass on Weight Loss Surgery Outcomes: 5 Years’ Experience
Galal, A. M., Boerma, E.-J. G., Fransen, S. A. F., Meesters, B., Damink, S. W. M. O., AlMageed, M. K. A., Sabry, A. A., Elsuity, A. H. M., & Greve, J. W. M. (2019) · Obesity Surgery · doi:10.1007/s11695-019-04229-0 · Cited by 13
New Metrics to Assess Type 2 Diabetes after Bariatric Surgery: The “Time-Within-Remission Range”
de Hollanda, A., Lecube, A., Rubio, M. Á., Sánchez, E., Vilarrasa, N., Oliva, J. G., Fernández‐Soto, M. L., Salas‐Salvadó, J., Ballesteros-Pomar, M. D., Ciudin, A., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041070 · Cited by 13
Metadata
- Authors
- Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., Kahn, R., & Kirkman, M. S.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Yale University (US)
- Pennington Biomedical Research Center (US)
- University of Warwick (GB)
- Department of Endocrinology & Metabolism, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy;
- University of Nebraska–Lincoln (US)
- University of Rochester Medicine (US)
- Pacific Northwest Research Institute (US)
- NewYork–Presbyterian Hospital (US)
- American Diabetes Association (US)
- Corresponding author
- Kirkman, M. Sue
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- 11
- Pages
- 2133-2135
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2768219
- OpenAlex
- W2138592519
- Cited by
- 1,003
- References
- 3
- Citations by year
- 2026: 26 · 2025: 37 · 2024: 38 · 2023: 46 · 2022: 74 · 2021: 85 · 2020: 101 · 2019: 90 · 2018: 78 · 2017: 85 · 2016: 78 · 2015: 66 · 2014: 57 · 2013: 63 · 2012: 46
- FWCI
- 18.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Research Information System (University of Udine) (submittedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diabetes cure, diabetes remission, glycemic control, hyperglycemia, type 1 diabetes, type 2 diabetes, islet transplantation, pancreas transplantation, bariatric surgery, metabolic surgery, immunomodulation
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Health Status, Humans, Reference Values, Remission Induction, Societies, Medical, United States, Genetic Predisposition to Disease, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.